“…1,3,4 Registry data from the United States and Canada indicate that propofol is used in 25% to 84% of PS episodes, 1,3,4 and midazolam in 15% to 42%. 1,3,4 Ketamine, etomidate, ketafol, and methohexital are used less commonly in adults, and ketamine and etomidate are associated with minor yet bothersome side effects (emergence and myoclonus, respectively), which may limit their widespread use in this patient population. 2,[5][6][7][8][9] Cohort studies, registry data, and small randomized controlled trials (RCTs) suggest that propofol and midazolam are safe and effective for use in PS.…”